Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
7227 studies found for:    MS
Show Display Options
Rank Status Study
1 Completed Therapy Optimization in Multiple Sclerosis (MS)
Condition: Multiple Sclerosis
Intervention: Drug: Glatiramer Acetate, IFN-beta 1a (IM), IFN-beta 1a (Subcutaneous), and IFN-beta 1b
2 Active, not recruiting Effect of Vitamin D Replacement on Immune Function and Cognition in MS Patients
Condition: Multiple Sclerosis (MS)
3 Completed A Phase I/II Study of GX15-070MS in Untreated CLL
Condition: Chronic Lymphocytic Leukemia
Intervention: Drug: GX15-070MS
4 Enrolling by invitation Single Test to ARrive at MS Diagnosis. Using a Single MRI Brain Scan to Help Diagnose Multiple Sclerosis
Condition: Multiple Sclerosis
5 Recruiting Efficacy of Cholecalciferol (Vitamin D3) for Delaying the Diagnosis of MS After a Clinically Isolated Syndrome
Condition: Multiple Sclerosis
Interventions: Drug: Vitamin D;   Drug: Placebo;   Other: Imaging;   Biological: Lumbar puncture;   Biological: Blood sampling;   Biological: Urine samples
6 Completed
Has Results
Oral Cladribine in Early Multiple Sclerosis (MS)
Condition: Multiple Sclerosis
Interventions: Drug: Cladribine;   Drug: Placebo;   Drug: Rebif® new formulation (RNF)
7 Not yet recruiting Reducing Sedentary Behaviour: A Novel Opportunity for Managing Comorbidity in MS?
Condition: Multiple Sclerosis
Intervention: Behavioral: Sit Less with MS
8 Unknown  Is MS14 Helpful in Schizophrenia?
Condition: Schizophrenia
Interventions: Drug: MS14;   Drug: Risperidone
9 Recruiting MEasuring Satisfaction of Treatment With REbif After Initial Treatment of MS (MESTRE-MS)
Condition: Multiple Sclerosis
Intervention: Drug: Rebif (IFNβ-1b)
10 Completed Pilot Clinical Trial of ACTHar Gel 14 Days Subcutaneous (SQ)Versus ACTHar Gel Five Days SQ for the Treatment of MS Exacerbations
Condition: Multiple Sclerosis (MS)
Intervention: Drug: H.P. Acthar Gel (repository corticotropin injection)
11 Not yet recruiting Integrating Caregiver Support Into MS Care
Condition: Multiple Sclerosis
Intervention: Behavioral: Behavioral
12 Unknown  Using Optical Coherence Tomography to Capture Retinal Microvascular Changes Associated With Multiple Sclerosis
Condition: Multiple Sclerosis
13 Completed Colecalciferol as an Add-on Treatment to Subcutaneously-Administered Interferon-beta-1b for Treatment of Multiple Sclerosis (MS)
Condition: Multiple Sclerosis
Intervention: Drug: colecalciferol
14 Recruiting Analysis of the Distribution of Regulatory B Cells in Blood of Multiple Sclerosis Patients
Conditions: Multiple Sclerosis;   Systemic Sclerosis
Intervention: Other: Blood sample collection
15 Not yet recruiting Tolerogenic Dendritic Cells as a Therapeutic Strategy for the Treatment of Multiple Sclerosis Patients (TOLERVIT-MS)
Conditions: Multiple Sclerosis, Relapsing-Remitting;   Multiple Sclerosis, Chronic Progressive
Interventions: Drug: Autologous VitD3 tolerogenic monocyte-derived dendritic cells loaded with a pool of myelin peptides (tolDC-VitD3);   Drug: Interferon-beta
16 Unknown  Venous Irregularities, Flow and Perfusion in MS Study
Condition: Venous Irregularities, Flow and Perfusion in MS and Non-MS Participants
17 Not yet recruiting MS PATHS Normative Sub-Study
Condition: Multiple Sclerosis (MS)
18 Unknown  Impact of Vitamin A on Multiple Sclerosis (MS)
Condition: Relapsing Remitting Multiple Sclerosis
Interventions: Dietary Supplement: vitamin A;   Drug: Drug: placebo
19 Unknown  Analysis of a Biomarker Signature in Patients With Multiple Sclerosis (MS) Treated With Gilenya (FTY720)
Condition: Multiple Sclerosis
20 Completed Safety, Pharmacokinetics and Pharmacodynamics After Multiple Oral Doses of BIBR 1048 MS Capsule in Healthy Japanese Male Subjects
Condition: Healthy
Intervention: Drug: BIBR 1048 MS

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.